Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema Types I and II”

36 trials

Showing 20 of 36 results

Large-scale testing (Phase 3)Study completedNCT00125151
What this trial is testing

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

Who this might be right for
Angioedema
Prothya Biosolutions 15
Testing effectiveness (Phase 2)Ended earlyNCT05055258
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Who this might be right for
Angioedema, Hereditary, Types I and II
KalVista Pharmaceuticals, Ltd. 33
Not applicableApproved For MarketingNCT06628713
What this trial is testing

Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Testing effectiveness (Phase 2)Study completedNCT01576523
What this trial is testing

Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 18
Not applicableStudy completedNCT07009262
What this trial is testing

A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 88
Not applicableNot Yet RecruitingNCT07218393
What this trial is testing

A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 100
Testing effectiveness (Phase 2)WithdrawnNCT01832896
What this trial is testing

Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
NYU Langone Health
Early research (Phase 1)Study completedNCT01760343
What this trial is testing

Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05505916
What this trial is testing

An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 145
Not applicableStudy completedNCT03029728
What this trial is testing

Biomarker for Hereditary AngioEdema Disease

Who this might be right for
C1 Esterase Inhibitor DeficiencyAngio EdemaC4 Deficiency+5 more
CENTOGENE GmbH Rostock 42
Not applicableEnded earlyNCT04091113
What this trial is testing

Hereditary Angioedema Kininogen Assay

Who this might be right for
Hereditary Angioedema
CENTOGENE GmbH Rostock 59
Not applicableStudy completedNCT03558009
What this trial is testing

Epidemiological Analysis for Hereditary Angioedema Disease

Who this might be right for
Abdominal PainFunctional Abdominal Pain
CENTOGENE GmbH Rostock 2,318
Large-scale testing (Phase 3)Study completedNCT02316353
What this trial is testing

Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 126
Large-scale testing (Phase 3)Study completedNCT06467084
What this trial is testing

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 36
Large-scale testing (Phase 3)Study completedNCT00997204
What this trial is testing

EASSI - Evaluation of the Safety of Self-Administration With Icatibant

Who this might be right for
Hereditary Angioedema
Shire 151
Large-scale testing (Phase 3)Study completedNCT05259917
What this trial is testing

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Large-scale testing (Phase 3)Study completedNCT02741596
What this trial is testing

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 212
Large-scale testing (Phase 3)Study completedNCT02586805
What this trial is testing

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 125
Not applicableActive Not RecruitingNCT05469789
What this trial is testing

Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 50
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation